Not logged in[18F]FDG PET/MRI FOR ASSESSING TREATMENT RESPONSE OF CNS LYMPHOMA: A PROSPECTIVE CASE SERIES
Lopez-Pereira, P.; Pons-Escoda, A.; Suarez, M.; Domingo-Domenech, E.; Martinez-Ramos, C.; Majos, C.; Gonzalez-Barca, E.; Villalobos, M.; Vidal, N.; Plans, G.; Bruna, J.; Cortes-Romera, M.; Sureda, A.; Velasco, R. .png)
Share.png)
SaveShare Save Initial results from the Canarian registry of luminal breast cancer patients treated with first-line CDK 4/6 inhibitorsCeballos Lenza, I.; Llabres Valenti, E.; Garcia Alonso, M.; Alvarez Ambite, R.; Hernandez Sosa, M.; Amurrio Quevedo, R. E.; Rodriguez Capote, A.; Hernandez Sarmiento, S.; Vicente Rubio, E.; Gonzalez Rivas, C. S.; Gutierrez Gordo, M.; Mendez Perez, A.; Perez Cabrera, D.; Del Pino Hernandez, C. V.; Rodriguez Garcia, J. A. R.; Cabrera Suarez, M. A.; Coca Membribes, S.; Vargas Prado, A. M.; Ramchandani Vaswani, A.; Cruz Jurado, J. Share Save Retrospective analysis of safety in elderly BRAF V600 mutation-positive advanced melanoma patients treated with dabrafenib (D) and trametinib (T) and correlation with non-elderly patientsGarcia-Castano, A.; Gonzalez-Barrallo, I.; Castellon Rubio, V. E.; Medina Martinez, J.; Manzano Mozo, J. L.; Mujika, K.; Majem Tarruella, M.; Aguado de La Rosa, C.; Cabrera Suarez, M. A.; Palacio, I.; Osterloh, L.; Martinez Fernandez, A. Share Save Activation of nuclear factor-κ B is linked to resistance to neloadjuvant chemotherapy in breast cancer patientsMontagut, C.; Tusquets, I.; Ferrer, B.; Corominas, J. M.; Bellosillo, B.; Campas, C.; Suarez, M.; Fabregat, X.; Campo, E.; Gascon, P.; Serrano, S.; Fernandez, P. L.; Rovira, A.; Albanell, J. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
